![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JD Coffin, RZ Florkiewicz, J Neumann, T Mort-Hopkins, GW Dorn , P Lightfoot, R German, PN Howles, A Kier and BA O'Toole
Department of Cell Biology, Scripps Research Institute, La Jolla, CA 92121, USA.
Basic fibroblast growth factor (FGF-2) is a pleiotropic growth factor detected in many different cells and tissues. Normally synthesized at low levels, FGF-2 is elevated in various pathologies, most notably in cancer and injury repair. To investigate the effects of elevated FGF-2, the human full-length cDNA was expressed in transgenic mice under control of a phosphoglycerate kinase promoter. Overexpression of FGF-2 caused a variety of skeletal malformations including shortening and flattening of long bones and moderate macrocephaly. Comparison by Western blot of FGF-2 transgenic mice to nontransgenic littermates showed expression of human FGF-2 protein in all major organs and tissues examined including brain, heart, lung, liver, kidney, spleen, and skeletal muscle; however, different molar ratios of FGF-2 protein isoforms were observed between different organs and tissues. Some tissues preferentially synthesize larger isoforms of FGF-2 while other tissues produce predominantly smaller 18-kDa FGF-2. Translation of the high molecular weight isoforms initiates from unconventional CUG codons and translation of the 18-kDa isoform initiates from an AUG codon in the FGF-2 mRNA. Thus the Western blot data from the FGF-2 transgenic mice suggest that tissue-specific expression of FGF-2 isoforms is regulated translationally.
This article has been cited by other articles:
|
|
 |
|
  A.-F. Bruns, J. van Bergeijk, C. Lorbeer, A. Nolle, J. Jungnickel, C. Grothe, and P. Claus Fibroblast growth factor-2 regulates the stability of nuclear bodies PNAS, August 4, 2009; 106(31): 12747 - 12752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xiao, P. Liu, X. Li, T. Doetschman, J. D. Coffin, H. Drissi, and M. M. Hurley Exported 18-kDa Isoform of Fibroblast Growth Factor-2 Is a Critical Determinant of Bone Mass in Mice J. Biol. Chem., January 30, 2009; 284(5): 3170 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zucchini, A. Buzzi, M. Barbieri, D. Rodi, B. Paradiso, A. Binaschi, J. D. Coffin, A. Marzola, P. Cifelli, O. Belluzzi, et al. FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss J. Neurosci., December 3, 2008; 28(49): 13112 - 13124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Panopoulos and V. P. Mauro Antisense Masking Reveals Contributions of mRNA-rRNA Base Pairing to Translation of Gtx and FGF2 mRNAs J. Biol. Chem., November 28, 2008; 283(48): 33087 - 33093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Alam, Q. Sun, L. Liu, D. L. Koller, Y. Liu, H. J. Edenberg, M. J. Econs, T. Foroud, and C. H. Turner Genomic expression analysis of rat chromosome 4 for skeletal traits at femoral neck Physiol Genomics, October 8, 2008; 35(2): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Shinohara, H.-J. Kim, J.-H. Kim, V. A. Garcia, and H. Cantor Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells PNAS, May 20, 2008; 105(20): 7235 - 7239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A.I. Virag, M. L. Rolle, J. Reece, S. Hardouin, E. O. Feigl, and C. E. Murry Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair: Effects on Cell Proliferation, Scar Contraction, and Ventricular Function Am. J. Pathol., November 1, 2007; 171(5): 1431 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hutchison, M. H. Bassett, and P. C. White Insulin-Like Growth Factor-I and Fibroblast Growth Factor, But Not Growth Hormone, Affect Growth Plate Chondrocyte Proliferation Endocrinology, July 1, 2007; 148(7): 3122 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Timmer, K. Cesnulevicius, C. Winkler, J. Kolb, E. Lipokatic-Takacs, J. Jungnickel, and C. Grothe Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion J. Neurosci., January 17, 2007; 27(3): 459 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bundschu, K.-P. Knobeloch, M. Ullrich, T. Schinke, M. Amling, C. M. Engelhardt, T. Renne, U. Walter, and K. Schuh Gene Disruption of Spred-2 Causes Dwarfism J. Biol. Chem., August 5, 2005; 280(31): 28572 - 28580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nowroozi, S. Raffioni, T. Wang, B. L. Apostol, R. A. Bradshaw, and L. M. Thompson Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells Hum. Mol. Genet., June 1, 2005; 14(11): 1529 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Qiao, P. Shapiro, R. Kumar, and A. Passaniti Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway J. Biol. Chem., October 8, 2004; 279(41): 42709 - 42718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Krezowski, D. Knudson, C. Ebeling, R. Pitstick, R. K. Giri, D. Schenk, D. Westaway, L. Younkin, S. G. Younkin, K. H. Ashe, et al. Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression Hum. Mol. Genet., September 15, 2004; 13(18): 1989 - 1997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kardami, Z.-S. Jiang, S. K Jimenez, C. J Hirst, F. Sheikh, P. Zahradka, and P. A Cattini Fibroblast growth factor 2 isoforms and cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 458 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Damron, S. Mathur, J. A. Horton, J. Strauss, B. Margulies, W. Grant, C. E. Farnum, and J. A. Spadaro Temporal Changes in PTHrP, Bcl-2, Bax, Caspase, TGF-{beta}, and FGF-2 Expression Following Growth Plate Irradiation With or Without Radioprotectant J. Histochem. Cytochem., February 1, 2004; 52(2): 157 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Murakami, G. Balmes, S. McKinney, Z. Zhang, D. Givol, and B. de Crombrugghe Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype Genes & Dev., February 1, 2004; 18(3): 290 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Thyagarajan, S. Totey, M. J. S. Danton, and A. B. Kulkarni GENETICALLY ALTERED MOUSE MODELS: THE GOOD, THE BAD, AND THE UGLY Critical Reviews in Oral Biology & Medicine, May 1, 2003; 14(3): 154 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Saito, K. Kusano, M. Kinosaki, H. Ito, M. Hirata, H. Segawa, K.-i. Miyamoto, and N. Fukushima Human Fibroblast Growth Factor-23 Mutants Suppress Na+-dependent Phosphate Co-transport Activity and 1alpha ,25-Dihydroxyvitamin D3 Production J. Biol. Chem., January 17, 2003; 278(4): 2206 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Kim, J.-H. Kim, S.-C. Bae, J.-Y. Choi, H.-J. Kim, and H.-M. Ryoo The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2 J. Biol. Chem., January 3, 2003; 278(1): 319 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kirsch, E. Koyama, M. Liu, E. E. Golub, and M. Pacifici Syndecan-3 Is a Selective Regulator of Chondrocyte Proliferation J. Biol. Chem., October 25, 2002; 277(44): 42171 - 42177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Xiao, D. Jiang, R. Gopalakrishnan, and R. T. Franceschi Fibroblast Growth Factor 2 Induction of the Osteocalcin Gene Requires MAPK Activity and Phosphorylation of the Osteoblast Transcription Factor, Cbfa1/Runx2 J. Biol. Chem., September 20, 2002; 277(39): 36181 - 36187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Rozenblatt-Rosen, E. Mosonego-Ornan, E. Sadot, L. Madar-Shapiro, Y. Sheinin, D. Ginsberg, and A. Yayon Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations J. Cell Sci., January 2, 2002; 115(3): 553 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sahni, R. Raz, J. D. Coffin, D. Levy, and C. Basilico STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2 Development, June 1, 2001; 128(11): 2119 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Creancier, D. Morello, P. Mercier, and A.-C. Prats Fibroblast Growth Factor 2 Internal Ribosome Entry Site (Ires) Activity Ex Vivo and in Transgenic Mice Reveals a Stringent Tissue-Specific Regulation J. Cell Biol., July 10, 2000; 150(1): 275 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alizadeh, C. M. Gelfman, S. R. Bench, and L. M. Hjelmeland Expression and Splicing of FGF Receptor mRNAs during APRE-19 Cell Differentiation In Vitro Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2357 - 2362. [Abstract] [Full Text]
|
|
|
|
|
|
A. Mansukhani, P. Bellosta, M. Sahni, and C. Basilico Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)-Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts J. Cell Biol., June 12, 2000; 149(6): 1297 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Parsons-Wingerter, K. E. Elliott, J. I. Clark, and A. G. Farr Fibroblast Growth Factor-2 Selectively Stimulates Angiogenesis of Small Vessels in Arterial Tree Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1250 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Monsonego-Ornan, R. Adar, T. Feferman, O. Segev, and A. Yayon The Transmembrane Mutation G380R in Fibroblast Growth Factor Receptor 3 Uncouples Ligand-Mediated Receptor Activation from Down-Regulation Mol. Cell. Biol., January 15, 2000; 20(2): 516 - 522. [Abstract] [Full Text]
|
|
|
|
|
|
C Hartmann and C. Tabin Dual roles of Wnt signaling during chondrogenesis in the chicken limb Development, January 7, 2000; 127(14): 3141 - 3159. [Abstract] [PDF]
|
|
|
|
|
|
D. Rice, T Aberg, Y Chan, Z Tang, P. Kettunen, L Pakarinen, R. Maxson, and I Thesleff Integration of FGF and TWIST in calvarial bone and suture development Development, January 5, 2000; 127(9): 1845 - 1855. [Abstract] [PDF]
|
|
|
|
|
|
D. G. McEwen, R. P. Green, M. C. Naski, D. A. Towler, and D. M. Ornitz Fibroblast Growth Factor Receptor 3 Gene Transcription Is Suppressed by Cyclic Adenosine 3',5'-Monophosphate. IDENTIFICATION OF A CHONDROCYTIC REGULATORY ELEMENT J. Biol. Chem., October 22, 1999; 274(43): 30934 - 30942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Touriol, A. Morillon, M.-C. Gensac, H. Prats, and A.-C. Prats Expression of Human Fibroblast Growth Factor 2 mRNA Is Post-transcriptionally Controlled by a Unique Destabilizing Element Present in the 3'-Untranslated Region between Alternative Polyadenylation Sites J. Biol. Chem., July 23, 1999; 274(30): 21402 - 21408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sahni, D.-C. Ambrosetti, A. Mansukhani, R. Gertner, D. Levy, and C. Basilico FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway Genes & Dev., June 1, 1999; 13(11): 1361 - 1366. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Arese, Y. Chen, R. Z. Florkiewicz, A. Gualandris, B. Shen, and D. B. Rifkin Nuclear Activities of Basic Fibroblast Growth Factor: Potentiation of Low-Serum Growth Mediated by Natural or Chimeric Nuclear Localization Signals Mol. Biol. Cell, May 1, 1999; 10(5): 1429 - 1444. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Wang, M. K. Spatz, K. Kannan, H. Hayk, A. Avivi, M. Gorivodsky, M. Pines, A. Yayon, P. Lonai, and D. Givol A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3 PNAS, April 13, 1999; 96(8): 4455 - 4460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arnaud, C. Touriol, C. Boutonnet, M.-C. Gensac, S. Vagner, H. Prats, and A.-C. Prats A New 34-Kilodalton Isoform of Human Fibroblast Growth Factor 2 Is Cap Dependently Synthesized by Using a Non-AUG Start Codon and Behaves as a Survival Factor Mol. Cell. Biol., January 1, 1999; 19(1): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Galy, A. Maret, A.-C. Prats, and H. Prats Cell Transformation Results in the Loss of the Density-dependent Translational Regulation of the Expression of Fibroblast Growth Factor 2 Isoforms Cancer Res., January 1, 1999; 59(1): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Houchen, R. J. George, M. A. Sturmoski, and S. M. Cohn FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G249 - G258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Mancilla, F. De Luca, J. A. Uyeda, F. S. Czerwiec, and J. Baron Effects of Fibroblast Growth Factor-2 on Longitudinal Bone Growth Endocrinology, June 1, 1998; 139(6): 2900 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ortega, M. Ittmann, S. H. Tsang, M. Ehrlich, and C. Basilico Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2 PNAS, May 12, 1998; 95(10): 5672 - 5677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Naski, J. Colvin, J. Coffin, and D. Ornitz Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3 Development, January 12, 1998; 125(24): 4977 - 4988. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Pepper Manipulating Angiogenesis: From Basic Science to the Bedside Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 605 - 619. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin Biological Roles of Fibroblast Growth Factor-2 Endocr. Rev., February 1, 1997; 18(1): 26 - 45. [Abstract] [Full Text]
|
|
